Abstract Details

Title VideoEEG Monitoring Safety at a Tertiary Epilepsy Center

Topic Epilepsy

Presentation(s) P06 - (-)

Poster/Presentation
Number 172

Objective

Background BACKGROUND: VideoEEG monitoring is a useful procedure in the diagnosis and classification of epilepsy, diagnosis of psychogenic non-epileptic seizures, and pre-surgical evaluation of medically intractable epilepsy. Potential risks of video-EEG monitoring include prolonged seizures, status epilepticus and risks associated with falls from seizures. Little data has been published on the frequency of adverse events occurring during video-EEG monitoring.

Design/Methods DESIGN/METHODS: This is a retrospective chart review of patients admitted to University of Kansas Hospital who underwent video-EEG monitoring between 11/1/2010 and 11/28/2011. Charts were identified by a search of the electronic medical record for an order for videoEEG. Charts were excluded if primary admission was to the ICU, age less than 1 year, intracranial electrodes were placed, or if videoEEG was performed for less than 24 hours.

Results RESULTS: 236 charts were identified. 49 charts were excluded. Of the remaining 187, 40% were male, 60% were female. Median LOS was 5 days (range 1-12). Median age was 37.3 years (range 10.5-83.3). 11 adverse events occurred: 4 falls without injury, 3 need of IV medications to terminate seizures, 3 tongue lacerations, 1 each shoulder dislocation, psychosis, and DVT due to PICC. Final diagnosis was psychogenic nonepileptic seizures 50%, nondiagnostic 13%, partial epilepsy 23%, generalized epilepsy 2%, other 2%.

Conclusions CONCLUSIONS: Adverse events in this case series are rare and most of the events were minor. Only 2 subjects needed additional care secondary to adverse events. This case series adds to the body of evidence that videoEEG monitoring is a safe procedure.

Authors/Disclosures
Nancy Hammond, MD, FAAN (University of Kansas Medical Center) PRESENTER	Dr. Hammond has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Healthline.
Susan Gauthier, DO (Weill Cornell Medicine)	Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Gauthier has received research support from Genentech.

��ɫ��

��ɫ��